These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 24779772)

  • 41. Rational Design and Synthesis of AT1R Antagonists.
    Georgiou N; Gkalpinos VK; Katsakos SD; Vassiliou S; Tzakos AG; Mavromoustakos T
    Molecules; 2021 May; 26(10):. PubMed ID: 34069122
    [TBL] [Abstract][Full Text] [Related]  

  • 42. QSAR study of angiotensin II antagonists using robust boosting partial least squares regression.
    Zhou YP; Cai CB; Huan S; Jiang JH; Wu HL; Shen GL; Yu RQ
    Anal Chim Acta; 2007 Jun; 593(1):68-74. PubMed ID: 17531825
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Telmisartan has the strongest binding affinity to angiotensin II type 1 receptor: comparison with other angiotensin II type 1 receptor blockers.
    Kakuta H; Sudoh K; Sasamata M; Yamagishi S
    Int J Clin Pharmacol Res; 2005; 25(1):41-6. PubMed ID: 15864875
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Design, synthesis, and biological evaluation of AT1 angiotensin II receptor antagonists based on the pyrazolo[3,4-b]pyridine and related heteroaromatic bicyclic systems.
    Cappelli A; Nannicini C; Gallelli A; Giuliani G; Valenti S; Mohr Gl; Anzini M; Mennuni L; Ferrari F; Caselli G; Giordani A; Peris W; Makovec F; Giorgi G; Vomero S
    J Med Chem; 2008 Apr; 51(7):2137-46. PubMed ID: 18318468
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Structural determinants for binding, activation, and functional selectivity of the angiotensin AT1 receptor.
    Balakumar P; Jagadeesh G
    J Mol Endocrinol; 2014 Oct; 53(2):R71-92. PubMed ID: 25013233
    [TBL] [Abstract][Full Text] [Related]  

  • 46. CoMFA and HQSAR studies on 6,7-dimethoxy-4-pyrrolidylquinazoline derivatives as phosphodiesterase10A inhibitors.
    Kulkarni SS; Patel MR; Talele TT
    Bioorg Med Chem; 2008 Apr; 16(7):3675-86. PubMed ID: 18299198
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Molecular characterisation of the interactions between olmesartan and telmisartan and the human angiotensin II AT1 receptor.
    Le MT; Pugsley MK; Vauquelin G; Van Liefde I
    Br J Pharmacol; 2007 Aug; 151(7):952-62. PubMed ID: 17572702
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Design and synthesis of new tetrazolyl- and carboxy-biphenylylmethyl-quinazolin-4-one derivatives as angiotensin II AT1 receptor antagonists.
    Ismail MA; Barker S; Abou el-Ella DA; Abouzid KA; Toubar RA; Todd MH
    J Med Chem; 2006 Mar; 49(5):1526-35. PubMed ID: 16509571
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Computer--based drug design, synthesis and biological evaluation of new pyrimidinone derivatives linked to arylpiperazine and 2'-carbethoxy-biphenylylmethyl moeities as alpha1-adrenoceptor antagonists and angiotensin II AT1 receptor antagonists.
    Ismail MA; Abou El Ella DA; Abouzid KA; Al-Ansary GH
    Pharmazie; 2010 Nov; 65(11):794-800. PubMed ID: 21155384
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Synthesis and evaluation of new designed multiple ligands directed towards both peroxisome proliferator-activated receptor-γ and angiotensin II type 1 receptor.
    Meyer M; Foulquier S; Dupuis F; Flament S; Grimaud L; Henrion D; Lartaud I; Monard G; Grillier-Vuissoz I; Boisbrun M
    Eur J Med Chem; 2018 Oct; 158():334-352. PubMed ID: 30223121
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Transdermal Delivery of AT1 Receptor Antagonists Reduce Blood Pressure and Reveal a Vasodilatory Effect on Kidney Blood Vessels.
    Michalatou M; Androutsou ME; Antonopoulos M; Vlahakos DV; Agelis G; Zulli A; Qaradakhi T; Mikkelsen K; Apostolopoulos V; Matsoukas J
    Curr Mol Pharmacol; 2018; 11(3):226-236. PubMed ID: 29676239
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Discovery of novel, potent and low-toxicity angiotensin II receptor type 1 (AT1) blockers: Design, synthesis and biological evaluation of 6-substituted aminocarbonyl benzimidazoles with a chiral center.
    Han XF; He X; Wang M; Xu D; Hao LP; Liang AH; Zhang J; Zhou ZM
    Eur J Med Chem; 2015 Oct; 103():473-87. PubMed ID: 26397395
    [TBL] [Abstract][Full Text] [Related]  

  • 53. 3D QSAR studies of 1,3,4-benzotriazepine derivatives as CCK2 receptor antagonists.
    Kaur K; Talele TT
    J Mol Graph Model; 2008 Nov; 27(4):409-20. PubMed ID: 18774323
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Rational design, efficient syntheses and biological evaluation of N,N'-symmetrically bis-substituted butylimidazole analogs as a new class of potent Angiotensin II receptor blockers.
    Agelis G; Resvani A; Koukoulitsa C; Tůmová T; Slaninová J; Kalavrizioti D; Spyridaki K; Afantitis A; Melagraki G; Siafaka A; Gkini E; Megariotis G; Grdadolnik SG; Papadopoulos MG; Vlahakos D; Maragoudakis M; Liapakis G; Mavromoustakos T; Matsoukas J
    Eur J Med Chem; 2013 Apr; 62():352-70. PubMed ID: 23376252
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Application of Multiscale Simulation Tools on GPCRs. An Example with Angiotensin II Type 1 Receptor.
    Erol I; Aksoydan B; Kantarcioglu I; Durdagi S
    Methods Mol Biol; 2018; 1824():431-448. PubMed ID: 30039423
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cerebral ischemia induced inflammatory response and altered glutaminergic function mediated through brain AT
    Justin A; Divakar S; Ramanathan M
    Biomed Pharmacother; 2018 Jun; 102():947-958. PubMed ID: 29710550
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Computational studies of TGF-βRI (ALK-5) inhibitors: analysis of the binding interactions between ligand-receptor using 2D and 3D techniques.
    Araujo SC; Maltarollo VG; Honorio KM
    Eur J Pharm Sci; 2013 Jul; 49(4):542-9. PubMed ID: 23727056
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Engineered mutation of some important amino acids in angiotensin II type 1 (AT1) receptor increases the binding affinity of AT1-receptor antagonists.
    Bhuiyan MA; Hossain M; Ishiguro M; Nakamura T; Nagatomo T
    J Pharmacol Sci; 2010; 113(1):57-65. PubMed ID: 20453435
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Participation of hepatic α/β-adrenoceptors and AT1 receptors in glucose release and portal hypertensive response induced by adrenaline or angiotensin II.
    de Araújo LJT; Nagaoka MR; Borges DR; Kouyoumdjian M
    Braz J Med Biol Res; 2018 Nov; 51(12):e7526. PubMed ID: 30462770
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Neuroprotection against retinal ischemia-reperfusion injury by blocking the angiotensin II type 1 receptor.
    Fukuda K; Hirooka K; Mizote M; Nakamura T; Itano T; Shiraga F
    Invest Ophthalmol Vis Sci; 2010 Jul; 51(7):3629-38. PubMed ID: 20164447
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.